Clinical trial
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
NCT00007657 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00007657 |
|---|---|
| Title | Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation |
| Official title | CSP #424 - Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Medical Research Council of Canada Merck Sharp & Dohme LLC Industry Pfizer GE Healthcare Bristol-Myers Squibb Astellas Pharma Inc AstraZeneca Sanofi Datascope Corp. First Horizon Kos Key… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Procedure |
| Interventions | Intensive medical therapy, Percutaneous Coronary Intervention (PCI) plus intensive medical therapy |
| Enrollment | 3,260 |
| Start date | Dec 1, 1998 |
| Completion | Jun 1, 2006 |
| First posted | Jan 4, 2001 |
| Last update posted | Jun 15, 2009 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: